Era of vaccination heralds a decline in incidence of hepatitis a in high- risk groups in China

Hepatitis Monthly

Volumn 12, Issue 2, 2012, Pages 100-105

  Fangcheng, Zhuang ^a,d   Xuanyi, Wang ^b   Mingding, Chen ^c   Liming, Jiang ^d   Jie, Wu ^d   Qi, Jiang ^e   Yuanping, Gong ^f   Wen, Qian ^a   Yajuan, Xin ^a   Jiangsen, Mao ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b FUDAN UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d Key Lab for Bio tech Vaccine Research   (China)

^e Center for Disease Control   (China)

^f Center for Disease Control   (China)

Author keywords

China; Hepatitis A; Vaccination

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; DRUG EFFICACY; HEPATITIS A; HUMAN; INCIDENCE; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT OUTCOME; VACCINATION;

EID: 84858252780     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.4907     Document Type: Article

References (18)

1. Marier R. The reporting of communicable diseases. Am J Epidemiol. 1977;105(6):587-590.
2. Xu ZY, Wang XY, Liu CQ, Li YT, Zhuang FC. Decline in the risk of hepatitis A virus infection in China, a country with booming economy and changing lifestyles. J Viral Hepat. 2008;15(Suppl 2):33-37.
3. Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis. 1989;159(4):621-624.
4. Mao JS. Development of live, attenuated hepatitis A vaccine (H2- strain). Vaccine. 1990;8(6):523-524.
5. WHO Expert Committee on Biological Standardization. Thirtyfourth report. World Health Organ Tech Rep Ser. 1984;700:1-75.
6. hui Zswzpbzhwy. Requirements for biologics of the People's Republic of China. Chemical Industry Press; 2000.
7. Bhave S, Bavdekar A, Madan Z, Jha R, Bhure S, Chaudhari J, et al. Evaluation of immunogenicity and tolerability of a live attenuated hepatitis a vaccine in Indian children. Indian Pediatr. 2006;43(11):983-987.
8. Faridi MM, Shah N, Ghosh TK, Sankaranarayanan VS, Arankalle V, Aggarwal A, et al. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study. Indian Pediatr. 2009;46(1):29-34.
9. Zhuang F, Jiang Q, Gong Y. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation]. Zhonghua Liu Xing Bing Xue Za Zhi. 2001;22(3):188-190.
10. Zhuang FC, Mao ZA, Jiang LM, Wu J, Chen YQ, Jiang Q, et al. [Longterm immunogencity and effectiveness of live attenuated heap titis A vaccine (H2-strain)-a study on the result of 15 years' follow up.]. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31(12):1332-1335.
11. Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine. 1997;15(9):944-947.
12. Wei S-B. Evaluation of epidemiological effectiveness of live attenuated hepatitis A vaccine inoculation of 500,000 target population. 7th international Conference of Infectious Disease Reports; 1996; Hongkong. Oxford Clinical Communications Australia; 1996.
13. Zhuang FC, Qian W, Mao ZA, Gong YP, Jiang Q, Jiang LM, et al. Persistent efficacy of live attenuated hepatitis A vaccine (H2- strain) after a mass vaccination program. Chin Med J (Engl). 2005;118(22):1851-1856.
14. Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, et al. Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine. 2000;19(4-5):470-474.
15. Dominguez A, Salleras L, Carmona G, Batalla J. Effectiveness of a mass hepatitis A vaccination program in preadolescents. Vaccine. 2003;21(7-8):698-701.
16. Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine. 2004;22(31-32):4342-4350.
17. Zhang S. [Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans]. Zhonghua Yi Xue Za Zhi. 1990;70(12):682-684, 48.
18. Wang XY, Xu ZY, Ma JC, von Seidlein L, Zhang Y, Hao ZY, et al. Longterm immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine. 2007;25(3):446-449.